Status:
COMPLETED
Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Neurologic Manifestations
Psychiatric Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Covid-19 pandemic now affects more than two million people worldwide. The neurotropism of the virus is assumed by its frequent association with neurological symptoms (anosmia, ageusia, headaches) but ...
Detailed Description
Pandemic context In December 2019, the first cases of SARS-CoV-2 coronavirus infection (Covid-19) appeared in Wuhan, Hubei Province, China. The virus quickly spread to other Chinese provinces and then...
Eligibility Criteria
Inclusion
- Age of 18 years or over
- Patient followed for a neurological or psychiatric pathology OR Patient consulting and presenting a neurological or psychiatric impairment AND
- Presenting a COVID-19 infection defined by at least one of the following three criteria:
- Biological diagnosis by any method for direct detection of the virus (Covid-19 positive PCR) or recent infection (serology)
- Typical chest imaging (CT scan or X-ray) in an epidemic area
- Clinical-biological data leading to a strong suspicion of current or past Covid-19 infection
- Non-opposition of the participant, relative or guardian to the research
Exclusion
- Patient under safety measure
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
730 Patients enrolled
Trial Details
Trial ID
NCT04362930
Start Date
April 27 2020
End Date
June 30 2022
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pitié Salpétrière
Paris, France, 75013